Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Baclofen in Cerebral Palsy Patients With Therapy-Resistant Spasticity
NCT00221611Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of baclofen in cerebral palsy (CP) and Spasticity, sponsored by Ghent University Hospital. Primary endpoint: Spasticity of patients at 4 years. Started Jan 2000; status: completed.
02
Drugs
baclofen
03
Conditions
cerebral palsy (CP)Spasticity
Beyond the preview
Go deeper on NCT00221611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221611.